Replication-competent AAV Serotype 2 (rcAAV2) Detection Kit

SKU:BHT20800123 Kits & Workflows
Overview
Click light‑blue chips for details
Replication-competent AAV Serotype 2 (rcAAV2) Detection Kit is a Viral Safety Testing Kit from Yeasen Biotechnology designed for Biopharmaceutical QC in bioanalytical method development research. Supplied as a pre-optimized kit with all critical reagents included.
Kit Category Detection / Quantification Kits
Grade RUO
Storage -20°C
Shipping Dry Ice
Options selector
Catalog no. Size
41327ES50 50 T
41327ES60 100 T
Field Specification
Product Type
  • Viral Safety Testing Kit
  • Replication-Competent AAV2 (rcAAV2) qPCR Detection
Shipping Dry Ice
Storage -20°C

Description

The Replication-competent AAV Serotype 2 (rcAAV2) Detection Kit is designed to quantitatively analyze and detect the potential risk of Replication Competent Adeno-associated Virus (rcAAV) in a variety of gene therapy, oncology and vaccine development products using recombinant adeno-associated viral vectors with AAV2 serotype.

This kit is based on the principle of fluorescent probe quantitative PCR, and uses qPCR to detect rAAV terminal

repeat sequence (ITR) (i.e. Reference gene) and rcAAV linked sequence (i.e. Target gene) respectively, realizing the quantitative detection of rAAV and rcAAV at the same time. The kit also contains DNA quantitative references for the reference gene and the target gene (rcAAV2 Reference&Target DNA Control).

Before using this kit, make sure that the sample to be tested also meets the following conditions:

1. The serotype of the adeno-associated virus in the sample to be tested is AAV2;

2. The ITR sequence of the recombinant adeno-associated viral vector rAAV in the sample to be tested needs to be matched with the ITR sequence of rAAV2 as described below:

>rAAV-2/N ITR sequence:

TTGGCCACTCCCTCTCTGCGCGCTCGCTCGCTCACTGAGGCCGGGCGACCAAAGGTCGCCCGACGCCCGGGCTTTGCCCGGGCGGCCTCAGTGAGCGAGCGAGCGCGCAGAGAGGGAGTGGCCAACTCCATCACTAGGGGTTCCT

Features

  • Compliance with regulations: the products are fully validated according to the requirements of Chp, USP, ICH, etc., and their performance is in line with Chinese and foreign regulations and standards;
  • Guarantee of quality: the raw materials of the kits are all self-developed, and the qPCR Mix and other enzyme products are produced in an ultra-clean enzyme factory;
  • High sensitivity: the lower limit of quantification (LLOQ) was 2 copies/uL;
  • High precision: high intra-batch reproducibility CV <10%, small inter-batch variation i.e. intermediate precision CV <15%;
  • Strong specificity: specific detection of rcAAV2 residual DNA without interference from other exogenous genomic DNA;
  • Strong anti-interference: the introduction of internal quality control (Reference) can exclude sample interference, abnormal reaction preparation and other factors, effectively avoiding false negatives.

Application

  • Residual rcAAV2 DNA test in biological products.

Specifications

Sensitivity

2 copies/uL (rang: Referenceand Target are all 2×1012×106copies/μL

Assay Time

~1.5 hours

Assay Principle

Fluorescent probe qPCR method

Required Instruments

Real-time fluorescence quantitative PCR system

Product Performance

Product Performance Validation Program

Reference standards or requirements

YEASEN

1. Standards for the kit

Homemade standards are available

Plasmid DNA containing Reference gene and Target gene

2. Linear Range

Assay Range

Refer to the actual situation

2x101~2x106 copies/μL

R2

≥0.98

≥0.99 and above

Slope

-3.1~-3.8

-3.1~-3.6

Amplification Efficiency

84%~109%

90%~109%

3. Accuracy

Recovery Rate

50%~150%

70%~130% and above

4. Precision

Repeatability

CV≤15%

10%

Intermediate precision

CV≤15%

15%

5. Exclusivity

No interference with DNA from other sources

Specific detection of rcAAV2 DNA without interference from other exogenous DNA

6. Sensitivity

Limit of quantification

Reliable quantification of the smallest concentrations of target substances

2 copies/μL

Limit of detection

Refer to the actual situation

0.125 copies/μL

7. Durability

Reagent Stability

Evaluating the effect of different storage temperatures on reagent performance

2~8°C for 30 days and 37°C for 14 days, and repeated freeze-thaw 10 times, the kit amplification efficiency is in the range of 90%~109%, R2≥0.99 and above

Instrument Compatibility

Kits are used on different devices without affecting the test results

Compatible with many types of qPCR Instruments (eg. Bio-Rad CFX96 Optic Module, Thermo Scientific ABI 7500, ABI Quant Studio 5)

Components

Components No.

Name

41327ES50

41327ES60

41327-A

rcAAV2 qPCR Mix

300 μL×2

600 μL×2

41327-B1

rcAAV2 Reference Primer&probe Mix

200 μL

400 μL

41327-B2

rcAAV2 Target Primer&probe Mix

200 μL

400 μL

41327-C

DNA Dilution Buffer

1.8 mL×2

1.8 mL×4

41327-D

rcAAV2 Reference&Target DNA Control (2×108 copies/μL)

50 μL

100 μL

Storage

This product should be stored at -25~-15℃ for 2 years.

Both 41327-A, 41327-B1 and 41327-B2 should be stored protected from light.

Figures

  • Limit of quantification

rcAAV2 DNA at concentrations of 2×101 copies/uL, 10 copies/uL, 5 copies/μL, 2 copies/μL and 1 copies/uL (with Target DNA and Reference DNA) were detected, with 10 replicates for each concentration, respectively. The results showed that the CV of rcAAV2 DNA was <20% at concentrations of 2copies/μL and above. Therefore, the limit of quantification in the rcAAV2 DNA residue detection kits was 2copies/μL.

Table 1. Limit of quantification (LOQ) assay results for rcAAV2 DNA

 

 

Repetition number

 

Test item

Target (copies/μL)

Reference (copies/μL)

Quantity

Return ratio

Quantity

Return ratio

1

2.34

117.01 %

1.97

98.63 %

2

2.13

106.26 %

1.92

96.22 %

3

2.06

103.24 %

2.45

122.39 %

4

1.99

99.43 %

2.15

107.52 %

5

1.93

96.26 %

1.78

89.14 %

6

1.93

96.56%

2.35

117.72 %

7

2.27

113.69%

1.80

90.16 %

8

2.38

119.10%

1.65

82.39 %

9

2.41

120.73%

1.88

94.25 %

10

1.85

92.43 %

1.83

91.40 %

Average value

2.13

\

1.98

\

CV

9.83%

\

13.87%

\

Figure 1. 2 copies/μL rcAAV2 DNA qPCR assay results

Figure 1. 2 copies/μL rcAAV2 DNA qPCR assay results

  • Limit of detection

The detection of Target and Reference at various concentration points under the quantitative limit, combined with the blank limit requirements, yields the detection limit of the reagent kit. The results show that at concentrations of 0.125 copies/μL and above, in 20 repeated wells, ≥19 wells are detected (i.e., the detection rate is ≥95%). Therefore, the detection limit of the replicative adeno-associated virus serotype 2 (rcAAV2) detection reagent kit can reach 0.125 copies/μL.

Table 2. Limit of detection (LOD) assay results for rcAAV2 DNA

 

 

Ct value

Theoretical concentration

Target (copies/μL)

Reference (copies/μL)

0.25

0.125

0.0625

0.25

0.125

0.0625

Positive count / Total count

20/20

19/20

18/20

20/20

19/20

19/20

Detection rate

100%

95%

90%

100%

95%

95%

 

 

 

 

 

 

 

 

Documents:

Safety Data Sheet

41327_MSDS_HB250310.pdf

Manuals

41327_Manual_Ver.EN20250310.pdf

What is replication-competent virus (RCV) testing and why is it required?

Replication-competent virus (RCV) — including RCL (lentivirus), RCR (retrovirus), and rcAAV — can form when recombination events during viral vector production reconstitute a replication-competent genome. Detection is mandatory for gene therapy product release under FDA (21 CFR 312.23), EMA, and ICH Q5A guidelines. Even trace amounts of RCV pose significant biosafety risks in clinical applications due to their potential to integrate and replicate in patient cells.

What is the sensitivity and specificity of this RCL/RCR/rcAAV detection kit?

This qPCR-based kit achieves high sensitivity with an LOD typically in the range of 1–10 copies per reaction for RCL/RCR detection, and less than 10 copies per reaction for rcAAV2 detection. Specificity is confirmed against wild-type viral sequences not present in replication-deficient vector preparations. Refer to the product datasheet for validated LOD, LOQ, and specificity data established with certified reference materials.

Is this kit suitable for GMP lot release testing?

This kit provides a research-grade (RUO) molecular tool for RCV detection with sensitivity appropriate for process development and QC screening. For GMP lot release submissions to regulatory agencies, full assay qualification (sensitivity, specificity, linearity, robustness) must be conducted per applicable guidelines (ICH Q2R1, USP <1033>). Consider this kit as a validated starting platform for developing a GMP-qualified method.

What sample types can be tested with this kit?

This kit is validated for purified nucleic acid extracted from viral vector preparations, cell culture supernatants, and drug substance/product samples. Pre-analytical steps (extraction method, input volume) should be optimized for your specific matrix. For complex matrices such as formulated drug products containing stabilizers or preservatives, spike-recovery experiments should confirm assay performance before routine use.

Yeasen Biotechnology offers flexible customization options for many of its assay kits and detection reagents, including custom lot sizes, bulk ordering, and application-specific formulation adjustments. Volume pricing, custom packaging, and kit bundling may be available depending on the product and intended workflow. A Certificate of Analysis (CoA) and lot-specific QC data are provided with every order. For inquiries regarding large-volume orders, custom configurations, or integration into automated workflows, please contact the BioHippo team for a tailored quotation.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Supplier Ads Slides show

Add dynamic ads with slider